4.7 Article

Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods

期刊

CANCER LETTERS
卷 293, 期 1, 页码 117-123

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2010.01.003

关键词

Circulating tumor cells; Metastatic colorectal cancer; EpCAM; Progression-free survival

类别

资金

  1. Austrian Research Promotion Agency (FFG)
  2. Janssen-Cilag Pharma, Austria

向作者/读者索取更多资源

Comprehensive in vitro and in vivo studies comparing EpCAM-based methods with other cytometric CTC enrichment technologies in metastatic colorectal cancer (mCRC) patients are lacking. We compare four manual cytometric methods to detect CTCs in vitro and in mCRC patients. The EpCAM-based technology, MACS HEA MicroBeads (R), showed a significant better tumor cell recovery rate compared to other cytometric methods (p-value <0.0001). CTCs of 38 mCRC patients were enriched with MACS HEA MicroBeads (R). Progression-free survival did significantly differ between mCRC patients without detectable and with >= 1 CTCs (p = 0.007). CTC enrichment with EpCAM coupled antibodies is superior to other cytometric methods and is a feasible method for CTC detection in mCRC patients. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据